Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes

Lipids Health Dis. 2010 Jul 20:9:75. doi: 10.1186/1476-511X-9-75.

Abstract

Background: The risk of cardiovascular disease is inversely correlated to level of plasma HDL-c. Moreover, reverse cholesterol transport (RCT) from peripheral tissues to the liver is the most widely accepted mechanism linked to the anti-atherosclerotic activity of HDL. The apolipoprotein A-I (apoA-I) and the ABC transporters play a key role in this process.Adipose tissue constitutes the body's largest pool of free cholesterol. The adipose cell could therefore be regarded as a key factor in cholesterol homeostasis. The present study investigates the capacity of primary cultures of mature human adipocytes to release cholesterol and explores the relationships between apoA-I, ABCA1, and apoE as well as the signaling pathways that could be potentially involved.

Results: We demonstrate that apoA-I induces a strong increase in cholesterol release and apoE secretion from adipocytes, whereas it has no transcriptional effect on ABCA1 or apoE genes. Furthermore, brefeldin A (BFA), an intracellular trafficking inhibitor, reduces basal cholesterol and apoE secretion, but does not modify induction by apoA-I. The use of statins also demonstrates that apoA-I stimulated cholesterol release is independent of HMG-CoA reductase activation.

Conclusion: Our work highlights the fact that adipose tissue, and particularly adipocytes, may largely contribute to RCT via a mechanism specifically regulated within these cells. This further supports the argument that adipose tissue must be regarded as a major factor in the development of cardiovascular diseases, in particular atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters / genetics
  • ATP-Binding Cassette Transporters / metabolism
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Adult
  • Apolipoprotein A-I / physiology*
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism*
  • Atherosclerosis / physiopathology
  • Cardiovascular Diseases / physiopathology*
  • Cells, Cultured
  • Cholesterol / metabolism*
  • Cyclic AMP / metabolism
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / metabolism
  • Middle Aged
  • Second Messenger Systems / drug effects
  • Secretory Pathway / drug effects
  • Subcutaneous Fat / cytology
  • Subcutaneous Fat / drug effects
  • Subcutaneous Fat / metabolism
  • Subcutaneous Fat / physiopathology
  • Time Factors

Substances

  • ABCA1 protein, human
  • APOA1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters
  • Apolipoprotein A-I
  • Apolipoproteins E
  • Enzyme Inhibitors
  • Cholesterol
  • Cyclic AMP
  • Hydroxymethylglutaryl CoA Reductases